RATIONALE: Air trapping and ventilation defects on imaging are characteristics of asthma. Airway wall thickening occurs in asthma and is associated with increased bronchial vascularity and vascular permeability. Vascular endothelial cell products have not been explored as a surrogate to mark structural airway changes in asthma. OBJECTIVES: Determine whether reporters of vascular endothelial cell perturbation correlate with airway imaging metrics in patients with asthma of varying severity. METHODS: Plasma from Severe Asthma Research Program subjects was analyzed by ELISAs for soluble von Willebrand factor mature protein (VWF:Ag) and propeptide (VWFpp), P-selectin, and platelet factor 4. Additional subjects were analyzed over 48 hours after whole-lung antigen challenge. We calculated ventilation defect volume by hyperpolarized helium-3 magnetic resonance imaging and areas of low signal density by multidetector computed tomography (less than -856 Hounsfield units [HU] at functional residual capacity and -950 HU at total lung capacity [TLC]). MEASUREMENTS AND MAIN RESULTS: VWFpp and VWFpp/Ag ratio correlated with and predicted greater percentage defect volume on hyperpolarized helium-3 magnetic resonance imaging. P-selectin correlated with and predicted greater area of low density on chest multidetector computed tomography less than -950 HU at TLC. Platelet factor 4 did not correlate. Following whole-lung antigen challenge, variation in VWFpp, VWFpp/Ag, and P-selectin among time-points was less than that among subjects, indicating stability and repeatability of the measurements. CONCLUSIONS: Plasma VWFpp and P-selectin may be useful as surrogates of functional and structural defects that are evident on imaging. The results raise important questions about why VWFpp and P-selectin are associated specifically with different imaging abnormalities.
RATIONALE: Air trapping and ventilation defects on imaging are characteristics of asthma. Airway wall thickening occurs in asthma and is associated with increased bronchial vascularity and vascular permeability. Vascular endothelial cell products have not been explored as a surrogate to mark structural airway changes in asthma. OBJECTIVES: Determine whether reporters of vascular endothelial cell perturbation correlate with airway imaging metrics in patients with asthma of varying severity. METHODS: Plasma from Severe Asthma Research Program subjects was analyzed by ELISAs for soluble von Willebrand factor mature protein (VWF:Ag) and propeptide (VWFpp), P-selectin, and platelet factor 4. Additional subjects were analyzed over 48 hours after whole-lung antigen challenge. We calculated ventilation defect volume by hyperpolarized helium-3 magnetic resonance imaging and areas of low signal density by multidetector computed tomography (less than -856 Hounsfield units [HU] at functional residual capacity and -950 HU at total lung capacity [TLC]). MEASUREMENTS AND MAIN RESULTS: VWFpp and VWFpp/Ag ratio correlated with and predicted greater percentage defect volume on hyperpolarized helium-3 magnetic resonance imaging. P-selectin correlated with and predicted greater area of low density on chest multidetector computed tomography less than -950 HU at TLC. Platelet factor 4 did not correlate. Following whole-lung antigen challenge, variation in VWFpp, VWFpp/Ag, and P-selectin among time-points was less than that among subjects, indicating stability and repeatability of the measurements. CONCLUSIONS: Plasma VWFpp and P-selectin may be useful as surrogates of functional and structural defects that are evident on imaging. The results raise important questions about why VWFpp and P-selectin are associated specifically with different imaging abnormalities.
Authors: Eduard E de Lange; Talissa A Altes; James T Patrie; John D Gaare; Jeffrey J Knake; John P Mugler; Thomas A Platts-Mills Journal: Chest Date: 2006-10 Impact factor: 9.410
Authors: Ashley Busacker; John D Newell; Thomas Keefe; Eric A Hoffman; Janice Cook Granroth; Mario Castro; Sean Fain; Sally Wenzel Journal: Chest Date: 2008-08-08 Impact factor: 9.410
Authors: Wendy C Moore; Deborah A Meyers; Sally E Wenzel; W Gerald Teague; Huashi Li; Xingnan Li; Ralph D'Agostino; Mario Castro; Douglas Curran-Everett; Anne M Fitzpatrick; Benjamin Gaston; Nizar N Jarjour; Ronald Sorkness; William J Calhoun; Kian Fan Chung; Suzy A A Comhair; Raed A Dweik; Elliot Israel; Stephen P Peters; William W Busse; Serpil C Erzurum; Eugene R Bleecker Journal: Am J Respir Crit Care Med Date: 2009-11-05 Impact factor: 21.405
Authors: Sean B Fain; Guillermo Gonzalez-Fernandez; Eric T Peterson; Michael D Evans; Ronald L Sorkness; Nizar N Jarjour; William W Busse; Janet E Kuhlman Journal: Acad Radiol Date: 2008-06 Impact factor: 3.173
Authors: Mats W Johansson; Stanley J Kruger; Mark L Schiebler; Michael D Evans; Ronald L Sorkness; Loren C Denlinger; William W Busse; Nizar N Jarjour; Robert R Montgomery; Deane F Mosher; Sean B Fain Journal: Am J Respir Crit Care Med Date: 2013-07-15 Impact factor: 21.405
Authors: Suphagaphan Ratanamaneechat; Donald R Neumann; Frank P Difilippo; Suzy A A Comhair; Kewal Asosingh; Sudakshina Ghosh; Deepa Grandon; Anam Khan; Mark A Aronica; Serpil C Erzurum Journal: Am J Respir Crit Care Med Date: 2014-03-15 Impact factor: 21.405
Authors: Stanley J Kruger; Scott K Nagle; Marcus J Couch; Yoshiharu Ohno; Mitchell Albert; Sean B Fain Journal: J Magn Reson Imaging Date: 2015-07-27 Impact factor: 4.813
Authors: Mats W Johansson; Brandon M Grill; Karina T Barretto; Molly C Favour; Hazel M Schira; Calvin M Swanson; Kristine E Lee; Ronald L Sorkness; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour Journal: Int Arch Allergy Immunol Date: 2020-08-10 Impact factor: 2.749